Objectives: To identify risk factors for KPC-producing Klebsiella pneumoniae (KPC-Kp) enteric colonization at intensive care unit (ICU) admission. Recently, the emergence and spread of KPC-producing Enterobacteriaceae in healthcare facilities has become an important issue. Understanding the extent of the reservoir in ICUs may be important for targeted intervention.
Introduction
Klebsiella pneumoniae has been shown to be one of the most common pathogens recovered in intensive care units (ICUs).
1,2
During 2007, a KPC-producing K. pneumoniae (KPC-Kp) isolate provoked the first Greek outbreak in the ICU of a university hospital on the island of Crete, Greece.
3 While this emergence brought particular attention in understanding and controlling its spread, KPC-Kp is widely disseminated throughout Greek hospitals, as reflected by a rapid increase in infections caused by such strains. 4 -6 The incidence of KPC-Kp infections was much higher among patients hospitalized in ICUs during the initial period of spread; however, more than half of such infections today are reported from internal medicine and surgery wards. 6 The European Antimicrobial Resistance Surveillance Network (EARSN) has declared that KPC-Kp is endemic in Greece and has spread in many European countries, causing small or interregional outbreaks. 7 The widespread dissemination of this organism, as well as its resistance to most available antibiotics, in particular to carbapenems, means that KPC-Kp is one of the most dangerous pathogens. 8 Early identification of risk factors for hospital-acquired infection, such as poor functional status, ICU stay and receipt of antibiotics, has to be considered the most important factor in controlling the spread of KPC-Kp infections.
4,9
Host colonization is a prerequisite for the development of infection. 10, 11 Although factors promoting the progression from colonization to infection are not well understood, most ICU-acquired infections are preceded by host colonization with the responsible microorganism. Surveillance screening of stool specimens or rectal or perirectal swabs usually produces a higher yield than testing of other body sites. 4 The aim of this study is to identify the risk factors for KPC-Kp faecal colonization of patients admitted to an ICU. 
Methods
This was a single-centre prospective study performed over a 22 month period (November 2009 to March 2011 and June 2011 to October 2011) in the 13 bed medical and surgical ICU of the University Hospital of Patras, Greece. Publication of patient data, informed consent and anonymity requirements are in agreement with the rules of the Ethics Committee of our institution (reference number: 571).
All consecutive patients (n ¼405) were included and treated according to standard clinical practice protocols applied in the ICU. Patients with positive KPC-Kp clinical samples (blood or urine) prior to ICU admission were included. Epidemiological data concerning demographic characteristics (age and sex), severity of illness scores on admission, chronic illnesses, length of prior hospitalization (hospitalization during the last year prior to ICU admission) and surgery and antibiotic usage before ICU admission were collected from the ICU computerized clinical information system (Criticus TM , University of Patras, Greece). Infection control measures for KPC-Kp were intensified. Several interventions to prevent transmission were introduced, including cohorting of colonized or infected patients when possible, implementation of contact precautions, reinforcement of hand hygiene policies and education of the staff by infection control personnel.
Within 12-48 h of admission, rectal samples were collected from all patients to determine their colonization status. Rectal swabs were inoculated on selective chromogenic agar (Oxoid). After 24 h of incubation at 378C, dark-blue colonies were identified at the species level by standard methods (Enterotube BD, BBL or VITEK 2). Antibiotic susceptibility testing was performed by the agar disc diffusion method (Kirby-Bauer), according to CLSI guidelines. The MICs of carbapenems (imipenem, meropenem and ertapenem), colistin and tigecycline were determined by using the Etest (AB Biodisk). All isolates were further screened for the production of KPC carbapenemase using the modified Hodge test and the boronic acid-imipenem disc test. 12 The presence of the bla KPC2 gene was confirmed by PCR, as described previously. 13 Statistical analysis was performed for categorical variables by using Fisher's exact test or the x 2 test, as appropriate. Continuous variables were compared using one-way analysis of variance (ANOVA) or the Wilcoxon rank-sum test, depending on the validity of the normality assumption. ORs and 95% CIs were calculated to evaluate the strength of any association. P,0.05 was considered significant and values are expressed as means+SD. Backward stepwise multiple logistic regression analysis was used to determine which variables were independently associated with colonization by KPC-Kp upon ICU admission. Both least-squares and logistic regression analyses used a backward elimination procedure to isolate the significant variables. At each stage of the elimination procedure, the variable with the largest current P value was eliminated until all remaining variables were or became statistically significant (P,0.05). The proportion of each variable (factor) significantly influencing the dependent variable in each model was defined as the coefficient of partial determination/coefficient of determination. Specifically, it was calculated using the following equation in which t¼t statistic, F¼F statistic and df¼degrees of freedom: % influence¼t 2 /(F×df). Receiver operating characteristic curves were constructed for logistic regression models by plotting y (sensitivity) against x (1 2specificity). The values for the area under this curve were determined to estimate the predictive power of each specific logistic regression model.
Results
Among a total of 405 ICU patients, 52 (12.8%) were found to be colonized by KPC-Kp upon admission during the study period. The results of univariate analysis of risk factors associated with KPC-Kp colonization are shown in Table 1 , while results from the multivariate analysis are given in Table 2 . The univariate analysis shows that most factors under consideration were statistically significant. Risk factors identified by logistic regression analysis were found to be previous ICU stay (OR 12.5; 95% CI 1.8 -86.8), chronic obstructive pulmonary disease (COPD) (OR 6.3; 95% CI 1.2 -31.9), duration of previous hospitalization (OR 1.3; 95% CI 1.1 -1.4), previous use of carbapenems (OR 5.2; 95% CI 1.0-26.2) and previous use of b-lactams/b-lactamase inhibitors (OR 6.7; 95% CI 1.4 -32.9).
Of the 405 ICU patients, 38 had been previously hospitalized in another ICU, 71 in medical wards and 58 in surgical wards, while the remaining 238 patients had no history of previous hospitalization and were admitted to the ICU directly from the emergency department. Among 238 patients who had never been previously hospitalized prior to ICU admission, no one was a KPC-Kp enteric carrier. However, 32 (84.2%) of 38 patients who had been previously hospitalized in other ICUs were found to be colonized. In order to determine risk factors for enteric colonization, 129 patients from medical or surgical wards prior to ICU transfer were further analysed. The univariate and multivariate analyses for risk factors are presented in Tables 3 and 4 , respectively. Thirteen out of 28 factors were found to be statistically significant by univariate analysis. Multivariable analysis showed that duration of hospitalization prior to ICU admission (OR 1.1; 95% CI 1.1 -1.3), number of comorbidities (OR 1.9; 95% CI 1.1-3.5), and number of antimicrobials administered (OR 2.1; 95% CI 1.3-3.3) were statistically significant.
All KPC-Kp isolates (n¼ 52, one isolate per patient) were positive for the presence of the bla KPC gene. For comparison, rates of resistance among strains from patients with or without previous ICU hospitalization are shown in Table 5 . Figure 1 shows patients with KPC-Kp enteric carriage at admission per month. During the first 6 months of the study, 4 out of 102 patients (3.9%) were KPC-Kp enteric carriers, while, during the following 16 months, 48 out of 303 (15.8%) patients were found to be colonized (P,0.001).
Discussion
The spread of KPC-Kp is an increasing problem restricting treatment options and resulting in frequent clinical failure in ICUs. The main finding of the present study is that 12.8% of ICU patients were enterically colonized with KPC-Kp upon admission. Furthermore, multivariate analysis revealed that KPC-Kp colonization is associated with previous ICU stay, duration of previous Administration for more than 3 days within last 6 months prior to ICU admission.
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hospitalization, COPD and previous use of carbapenems or b-lactams/b-lactamase inhibitors.
Similarly to the present study, previous ICU stay was identified as an important risk factor for infection and/or colonization by carbapenemase-producing Enterobacteriaceae in other studies. 10,14 -17 In healthcare settings, ICUs are the main reservoirs of Gram-negative multidrug-resistant bacteria and present ample opportunities for cross-transmission from patient to patient. Giakkoupi et al. 6 showed that 150 (47%) out of 320 KPC-Kp clinical isolates in Greece were derived from ICU patients.
Length of previous hospitalization has also been found to be an independent risk factor for KPC-Kp colonization. 17 -19 Furthermore, the present study shows the duration of previous hospitalization is significantly longer among colonized patients than among Within last month prior to ICU admission. c Hospitalization within last year prior to ICU admission. d Administration for more than 3 days within last 6 months prior to ICU admission. e Only intravenous administration of colistin in patients is included.
Risk factors for KPC-producing K. pneumoniae upon ICU admission 2979 JAC non-colonized ones (42+49 versus 7+5 days; P,0.001). It seems that a longer hospital stay in peripheral wards prior to ICU transfer leads to and reflects the cross-transmission of such strains.
Falagas et al. 17 identified COPD as an independent risk factor for infection/colonization by KPC-Kp. According to our data, the role of COPD may have been overestimated in the past, due to the fact that such patients had longer previous hospitalization as compared with those without COPD (23+40 versus 5+16 days, P,0.001). Most of them were previously hospitalized in ICUs [20/60 patients (33.3%) versus 18/345 (5.2%), P,0.001].
Like in other studies, the number and specific classes of antibiotics were significantly associated with carbapenemaseproducing Enterobacteriaceae infections/colonization. 10,11,14 -21 In the present study, the antibiotics linked to KPC-Kp colonization were carbapenems and b-lactams/b-lactamase inhibitors. Most studies have found that prior exposure to carbapenems is an independent risk factor. 14 -19,21 Apart from carbapenems, aminopenicillins and anti-Pseudomonas penicillins with or without b-lactamase inhibitors have also been identified as independent risk factors. 11, 14, 17, 21 In contrast to previous studies that examined risk factors for infection or infection/colonization by carbapenemase-producing Enterobacteriaceae, this prospective study focused only at risk factors for colonization. In addition, we tried to elucidate the extent of the problem in non-ICU wards prior to ICU admission.
The KPC-Kp isolates from patients with prior ICU stay, compared with those without prior ICU stay, were significantly more resistant to gentamicin (59.4% versus 10.0%; P,0.001) and colistin (50.0% versus 15.0%; P,0.001), while no difference was found in resistance to tigecycline (25.0% versus 15.0%; P,0.274) and carbapenems (84.4% versus 70.0%; P,0.187). Colistin resistance of Gram-negative bacteria depends on its previous administration. 22 Our findings may be explained by the fact that, in addition to a longer length of previous ICU stay, these patients were extensively treated with gentamicin and colistin. More specifically, 12 (31.6%) and 14 (36.8%) out of 38 patients with previous ICU stay received colistin and gentamicin, respectively, compared with 1 (0.8%) and 4 (3.1%) out of 129 patients, respectively, who had previously stayed in medical or surgical wards.
As is shown in Figure 1 , the percentage of colonized patients during the first 6 months was significantly lower than the percentage in the following 16 months (3.9% versus 15.8% of admissions; P,0.001). This is also reflected in our clinical laboratory, where an increase in KPC-Kp isolates from all clinical samples of the hospital is observed (M. Christofidou, unpublished data). Administration for more than 3 days within last 6 months prior to ICU admission. Papadimitriou-Olivgeris et al.
In conclusion, the present study shows a high percentage of KPC-Kp enteric carriage upon ICU admission, which is associated with previous ICU stay, duration of previous hospitalization, previous use of antimicrobials, especially carbapenems or b-lactams/lactamase inhibitors, and number of comorbidities such as COPD. In countries such as Greece, where KPC-Kp is endemic, future studies are needed to clarify if early detection through targeted surveillance in combination with implementation of strict infection control measures might limit further spread of such pathogens and lead to a reduction of ICU morbidity and mortality.
